TickerFacts.

Carlsmed, Inc. (CARL): Revenue

Annual figures by period end, from SEC filings.

$50.51M
Year ended 2025-12-31
$63.30M
Trailing 12 months to 2026-06-30
2024-12-31: $27.16M2025-12-31: $50.51M$50.51M
2024-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$50.51M+85.9%2026-02-25, From 2025-01-01
2024-12-31$27.16Mn/a2026-02-25, From 2024-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Carlsmed, Inc. (CARL)2025-12-31$50.51M+85.9%
Apyx Medical Corp (APYX)2025-12-31$52.84M+9.9%
Shoulder Innovations, Inc. (SI)2025-12-31$47.32M+49.6%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$45.15M+53.4%
CVRx, Inc. (CVRX)2025-12-31$56.65M+10.4%
SANUWAVE Health, Inc. (SNWV)2025-12-31$44.05M+35.0%
LENSAR, Inc. (LNSR)2025-12-31$58.44M+9.2%
SS Innovations International, Inc. (SSII)2025-12-31$42.48M+105.7%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$61.79M-36.2%

Compare CARL, APYX, SI, TLSI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗